Amendment to the guidance on communication by biotech companies
Finance Classified by Officially
The FSMA has amended its Biotech Opinion following the entry into force in June 2026 of the provisions of the Listing Act that amended the Market Abuse Regulation with regard to protracted processes.The Opinion takes into account Delegated Regulation (EU) 2026/789[1], which was published in July 2026 and contains, amongst others, a non-exhaustive list of final events or final circumstances in pr …
This is an extract. The publication continues at the source.
Read the original at the source: http://www.fsma.be/en/news/amendment-guidance-communication-biotech-companies
Officially imported this from FSMA’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
Provenance
- Organization
- FSMA — imported from official source
- Official source
- https://www.fsma.be/en/news-articles/rss.xml RSS
- Imported
- October 15, 2026 06:33
- Versions
- 1 recorded
- Identity
-
644675